These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32808348)

  • 1. Deficiency of pseudogene UPAT leads to hepatocellular carcinoma progression and forms a positive feedback loop with ZEB1.
    Xiang L; Huang X; Wang S; Ou H; Chen Z; Hu Z; Huang Y; Li X; Yuan Y; Yang D
    Cancer Sci; 2020 Nov; 111(11):4102-4117. PubMed ID: 32808348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. lncRNA TUG1-Mediated Mir-142-3p Downregulation Contributes to Metastasis and the Epithelial-to-Mesenchymal Transition of Hepatocellular Carcinoma by Targeting ZEB1.
    He C; Liu Z; Jin L; Zhang F; Peng X; Xiao Y; Wang X; Lyu Q; Cai X
    Cell Physiol Biochem; 2018; 48(5):1928-1941. PubMed ID: 30092578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA HULC enhances epithelial-mesenchymal transition to promote tumorigenesis and metastasis of hepatocellular carcinoma via the miR-200a-3p/ZEB1 signaling pathway.
    Li SP; Xu HX; Yu Y; He JD; Wang Z; Xu YJ; Wang CY; Zhang HM; Zhang RX; Zhang JJ; Yao Z; Shen ZY
    Oncotarget; 2016 Jul; 7(27):42431-42446. PubMed ID: 27285757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GINS1 promotes ZEB1-mediated epithelial-mesenchymal transition and tumor metastasis via β-catenin signaling in hepatocellular carcinoma.
    Liang J; Yao N; Deng B; Li J; Jiang Y; Liu T; Hu Y; Cao M; Hong J
    J Cell Physiol; 2024 May; 239(5):e31237. PubMed ID: 38468464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGFBP2 upregulates ZEB1 expression and promotes hepatocellular carcinoma progression through NF-κB signaling pathway.
    Guo Q; Yu DY; Yang ZF; Liu DY; Cao HQ; Liao XW
    Dig Liver Dis; 2020 May; 52(5):573-581. PubMed ID: 31818638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA SNHG3 Promotes Hepatocellular Tumorigenesis by Targeting miR-326.
    Zhao Q; Wu C; Wang J; Li X; Fan Y; Gao S; Wang K
    Tohoku J Exp Med; 2019 Sep; 249(1):43-56. PubMed ID: 31548493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
    Qiu G; Lin Y; Zhang H; Wu D
    Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ZEB1 promotes tumorigenesis and metastasis in hepatocellular carcinoma by regulating the expression of vimentin.
    Qin Y; Yu J; Zhang M; Qin F; Lan X
    Mol Med Rep; 2019 Mar; 19(3):2297-2306. PubMed ID: 30664206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological significance of ZEB1 protein in patients with hepatocellular carcinoma.
    Zhou YM; Cao L; Li B; Zhang RX; Sui CJ; Yin ZF; Yang JM
    Ann Surg Oncol; 2012 May; 19(5):1700-6. PubMed ID: 21584833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Super-Enhancer-Associated Long Noncoding RNA HCCL5 Is Activated by ZEB1 and Promotes the Malignancy of Hepatocellular Carcinoma.
    Peng L; Jiang B; Yuan X; Qiu Y; Peng J; Huang Y; Zhang C; Zhang Y; Lin Z; Li J; Yao W; Deng W; Zhang Y; Meng M; Pan X; Li C; Yin D; Bi X; Li G; Lin DC
    Cancer Res; 2019 Feb; 79(3):572-584. PubMed ID: 30482773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A long non-coding RNA lncRNA-PE promotes invasion and epithelial-mesenchymal transition in hepatocellular carcinoma through the miR-200a/b-ZEB1 pathway.
    Shen Y; Liu S; Yuan H; Ying X; Fu H; Zheng X
    Tumour Biol; 2017 May; 39(5):1010428317705756. PubMed ID: 28488544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor suppressor DCAF15 inhibits epithelial-mesenchymal transition by targeting ZEB1 for proteasomal degradation in hepatocellular carcinoma.
    Dong X; Han Y; Zhang E; Wang Y; Zhang P; Wang C; Zhong L; Li Q
    Aging (Albany NY); 2021 Apr; 13(7):10603-10618. PubMed ID: 33833131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transition.
    Wang TH; Lin YS; Chen Y; Yeh CT; Huang YL; Hsieh TH; Shieh TM; Hsueh C; Chen TC
    Oncotarget; 2015 Sep; 6(27):23342-57. PubMed ID: 26160837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of long noncoding RNA linc-ITGB1 suppresses migration, invasion of hepatocellular carcinoma via regulating ZEB1.
    Yu WW; Wang K; Liao GJ
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5089-5095. PubMed ID: 29228420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
    Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The miR-200b-ZEB1 circuit regulates diverse stemness of human hepatocellular carcinoma.
    Tsai SC; Lin CC; Shih TC; Tseng RJ; Yu MC; Lin YJ; Hsieh SY
    Mol Carcinog; 2017 Sep; 56(9):2035-2047. PubMed ID: 28383782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deubiquitinase USP39 and E3 ligase TRIM26 balance the level of ZEB1 ubiquitination and thereby determine the progression of hepatocellular carcinoma.
    Li X; Yuan J; Song C; Lei Y; Xu J; Zhang G; Wang W; Song G
    Cell Death Differ; 2021 Aug; 28(8):2315-2332. PubMed ID: 33649471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ZEB1 enhances Warburg effect to facilitate tumorigenesis and metastasis of HCC by transcriptionally activating PFKM.
    Zhou Y; Lin F; Wan T; Chen A; Wang H; Jiang B; Zhao W; Liao S; Wang S; Li G; Xu Z; Wang J; Zhang J; Ma H; Lin D; Li Q
    Theranostics; 2021; 11(12):5926-5938. PubMed ID: 33897890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ELF3 promotes epithelial-mesenchymal transition by protecting ZEB1 from miR-141-3p-mediated silencing in hepatocellular carcinoma.
    Zheng L; Xu M; Xu J; Wu K; Fang Q; Liang Y; Zhou S; Cen D; Ji L; Han W; Cai X
    Cell Death Dis; 2018 Mar; 9(3):387. PubMed ID: 29523781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Conserved LncRNA DIO3OS Restricts Hepatocellular Carcinoma Stemness by Interfering with NONO-Mediated Nuclear Export of ZEB1 mRNA.
    Hou YR; Diao LT; Hu YX; Zhang QQ; Lv G; Tao S; Xu WY; Xie SJ; Zhang Q; Xiao ZD
    Adv Sci (Weinh); 2023 Aug; 10(23):e2301983. PubMed ID: 37271897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.